Skip to content
10-K

Annual Report

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

0001091818-24-000034

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 1, 2024 29.27M sh
Shares Diluted FY 2023 · Dec 31, 2022 29.27M sh
Operating Cash Flow FY 2023 · Dec 31, 2022 −$68.39K
Cash And Equivalents FY 2023 · Dec 31, 2022 $734
Current Liabilities FY 2023 · Dec 31, 2022 $1.35M
Total Liabilities FY 2023 · Dec 31, 2022 $1.35M
Current Assets FY 2023 · Dec 31, 2022 $734
Total Assets FY 2023 · Dec 31, 2022 $734
Eps Diluted FY 2023 · Dec 31, 2022 −$0.02
Eps Basic FY 2023 · Dec 31, 2022 −$0.02
Sga Expense FY 2023 · Dec 31, 2022 $62.51K
Net Income FY 2023 · Dec 31, 2022 −$485.51K
Stockholders Equity FY 2023 · Dec 31, 2021 −$861.86K